STEPHANIE COLLINS: Open Payments
NPI 1326152182 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 117 payments from 18 companies in 2025. Trend: 2023 $1,055 · 2024 $1,508 · 2025 $1,834
Food & beverage: $1,800Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $496 |
| BioCryst US Sales Co., LLC | 34 | $289 |
| Grifols USA, LLC | 21 | $213 |
| Novartis Pharmaceuticals Corporation | 9 | $137 |
| Genentech USA, Inc. | 6 | $117 |
| GENZYME CORPORATION | 3 | $81 |
| Amgen Inc. | 3 | $76 |
| Pharming Healthcare, Inc. | 3 | $68 |
| CSL Behring | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
Products named: TEZSPIRE, ORLADEYO, Xembify, AIRSUPRA, Xolair, DUPIXENT, RUCONEST, FASENRA.
Industry payments across FL — which companies pay providers there.
